Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

FDA Grants Orphan Drug Status To Centessa’s Hemophilia B Candidate

By Ragothaman Srinivasan
September 14, 10:07 AM
Centessa Pharmaceuticals (NASDAQ: CNTA) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to SerpinPC for the treatment of hemophilia B. A Phase 2a proof-of-concept study evaluated SerpinPC in severe hemophilia A and B patients not on prophylaxis.

CNTA

Read More
2 minute read

Barnwell Industries And 3 Other Penny Stocks Insiders Are Aggressively Buying

By Lisa Levin
September 14, 8:52 AM
The Nasdaq Composite dipped by more than 600 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BRN